Dapsone syndrome - A five year retrospective analysis

Indian Journal of Leprosy

Volumn 70, Issue 3, 1998, Pages 271-276

  Kumar, R H ^a   Kumar, M V ^a   Thappa, D M ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CORTICOSTEROID; DAPSONE; LIVER ENZYME;

ADOLESCENT; ADULT; ARTICLE; BULLOUS SKIN DISEASE; CHILD; CLINICAL ARTICLE; DRUG INDUCED DISEASE; ECZEMA; EROSION; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HEMOLYTIC ANEMIA; HEPATIC ENCEPHALOPATHY; HEPATOMEGALY; HUMAN; INTRACUTANEOUS TEST; JAUNDICE; LEPROSY; LICHEN PLANUS; LYMPHADENOPATHY; MALE; ORAL DRUG ADMINISTRATION; PAPULE; PHOTOSENSITIVITY DISORDER; PROVOCATION TEST; PRURITUS; RETROSPECTIVE STUDY; SPLENOMEGALY; SYMPTOMATOLOGY; SYNDROME;

ADOLESCENT; ADULT; CHILD; DAPSONE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; LEPROSY; LIVER; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYNDROME;

EID: 0031758651     PISSN: 02549395     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Allday EJ, Barnes J 1951. Toxic effects of diamino diphenyl sulphone in leprosy. Lancet ii: 205-206.
2. Aurora R, Hortaleza MAAR, Salta-Ramos NG 1995. Dapsone syndrome in a Filipino man. Lepr Rev 66: 307-313.
3. Frey HM, Gershon AA, Borkowsky W, Bullock WE 1981. Fatal reaction to dapsone during treatment of leprosy. Ann Int Med 94: 777-779.
4. Gokhale NR, Sule RR, Gharpure MB 1992. Dapsone syndrome. Indian J Dermatol Venereol Leprol 58: 376-378.
5. Grossmann SJ, Jollow DJ 1988. Role of dapsone hydroxylamine in dapsone induced hemolytic anaemia. J Pharmacol Exp Ther 244: 118-125.
6. Jacobson RR 1985. Treatment, In Leprosy, ed RC Hastings, Edinburgh, Churchill Livingstone, p 198.
7. Jopling WH, Mc Dougall AC 1988. Chemotherapy, In Handbook of Leprosy, Edn 4, Oxford, Heinemann, pp 103-107.
8. Joseph MS 1985. Hypersensitivity reaction to dapsone. Four case reports. Lepr Rev 56: 315-320.
9. Lowe J 1950. Treatment of leprosy with diamino diphenyl sulphone. Lancet i: 145-150.
10. May DG, Porter J, Wilkinson G 1994. Frequency distribution of dapsone N-hydroxylase, a putative probe for p 4503 A4 activity in a white population. Clin Pharmacol Ther 55: 492-500.
11. Prussick R, Shear NH 1996. Dapsone hypersensitivity syndrome. J Am Acad Dermatol 35: 346-349.
12. Ramanujam K, Ramu G 1968. Toxic reactions to parent sulphone: report of four cases. Lepr India 40: 1-7.
13. Rege VL, Shukla P, Mascarenhas MF 1994. Dapsone syndrome in Goa. Indian J Lepr 66: 59-64.
14. Richardus JJ, Smith TC 1989. Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidmg therapy. Lepr Rev 60: 267-273.
15. Saito S, Ikezawa Z, Miyamoto H, Kim S 1994. A case of the 'dapsone syndrome'. Clin Exp Dermatol 19: 152-156.
16. Sharma VK, Kaur S, Kumar B, Singh M 1985. Dapsone syndrome in India, Indian J Lepr 57: 807-812.
17. Shear NH, Spielberg SP, Grant DM 1986. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 105: 179-184.
18. Singal A, Sharma SC, Baruah MC, Gautam RK 1993. Early onset dapsone syndrome. Indian J Lepr 65: 443-445.
19. Smith WSC 1989. Are hypersensitivity reactions to dapsone becoming more frequent? Lepr Rev 59: 53-58.
20. Tomecki KJ, Catalano CJ 1981. Dapsone hypersensitivity. Arch Dermatol 117: 38-39.